Analysis of the characteristics of retracted scientific papers in the field of global liver diseases published by Chinese scholars.
10.3760/cma.j.cn501113-20210324-00138
- Author:
Qing Yao ZHONG
1
;
Xin Yi ZHANG
1
;
Hong Hui LUO
1
;
Xin JIANG
2
;
Xin Yi ZENG
2
;
Jiao JIANG
2
;
Hui Fang XIA
2
;
Yan PENG
2
;
Mu Han LYU
2
;
Xiao Wei TANG
2
Author Information
1. Department of Gastenterology, The Affiliated Hospital of South West Medical University, Luzhou 646000, China Clinical College of South West Medical University, Luzhou 646000, China.
2. Department of Gastenterology, The Affiliated Hospital of South West Medical University, Luzhou 646000, China.
- Publication Type:Journal Article
- Keywords:
Liver;
Liver disease;
Retraction Watch Database;
Retraction papers
- MeSH:
Humans;
Biomedical Research;
China;
Liver Diseases;
Scientific Misconduct
- From:
Chinese Journal of Hepatology
2023;31(1):96-100
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the characteristics of scientific papers in the field of global liver diseases published by Chinese scholars that were retracted for diverse reasons from the Retraction Watch database, so as to provide a reference to publishing-related papers. Methods: The Retraction Watch database was retrieved for retracted papers in the field of global liver disease published by Chinese scholars from March 1, 2008 to January 28, 2021. The regional distribution, source journals, reasons for retraction, publication and retraction times, and others were analyzed. Results: A total of 101 retracted papers that were distributed across 21 provinces/cities were retrieved. Zhejiang area (n = 17) had the most retracted papers, followed by Shanghai (n = 14), and Beijing (n = 11). The vast majority were research papers (n = 95). The journal PLoS One had the highest number of retracted papers. In terms of time distribution, 2019 (n = 36) had the most retracted papers. 23 papers, accounting for 8.3% of all retractions, were retracted owing to journal or publisher concerns. Liver cancer (34%), liver transplantation (16%), hepatitis (14%), and others were the main areas of retracted papers. Conclusion: Chinese scholars have a large number of retracted articles in the field of global liver diseases. A journal or publisher chooses to retract a manuscript after investigating and discovering more flawed problems, which, however, require further support, revision, and supervision from the editorial and academic circles.
